Our Core Competence: Tailor-Made Formulation Design

MCS excels when it comes to formulation design of "critical drugs". These are early or late-stage compounds that may not show the desired safety profiles or may not be freely soluble, inherently stable or readily bioavailable. To these end MCS offers the adequate drug delivery tools.

MCS' core competence at a glance:

Formulation of poorly soluble & unstable drugs

Drug solubilisation by encapsulation into colloidal drug carriers

Resolution of product stability issues

Improvement of pharmacodynamics & pharmacokinetics

Drug targeting
(Enriched drug concentration at local site of action

Modified drug release

Improved bioavailability

Elimination of adverse ADME profiles

Adapted safety profiles

Adaptation to innovative dosage forms

Adapted drug half-life resulting in reduced dosing frequency

Design of individual pharmaceutical forms
[Pharmacogenomic Based Drug Dosing (Cytochrome P450 subtypes for slow or fast metabolising effect)]

Drug carrier surface modification with a target ligand

See: Formulation Design Benefits